Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee
- PMID: 40737572
- DOI: 10.1212/WNL.0000000000214014
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee
Erratum for
-
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee.Neurology. 2025 Jun 10;104(11):e213604. doi: 10.1212/WNL.0000000000213604. Epub 2025 May 14. Neurology. 2025. PMID: 40367405 Review.
Publication types
LinkOut - more resources
Full Text Sources